Cargando…
Polymorphisms in the PTPN22 region are associated with psoriasis of early onset
BACKGROUND: Psoriasis, a chronic inflammatory skin disease, affects approximately 2% of the population worldwide. Although the aetiology of psoriasis is poorly understood, patients with disease of early onset (Type I, age of onset ≤ 40 years) usually have a strong genetic component to the disease. O...
Autores principales: | Smith, RhLl, Warren, RB, Eyre, S, Ke, X, Young, HS, Allen, M, Strachan, D, McArdle, W, Gittins, MP, Barker, JNWN, Griffiths, CEM, Worthington, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2342636/ https://www.ncbi.nlm.nih.gov/pubmed/18341666 http://dx.doi.org/10.1111/j.1365-2133.2008.08482.x |
Ejemplares similares
-
Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms
por: Warren, RB, et al.
Publicado: (2009) -
Association of LACC1, CEBPB-PTPN1, RIPK2 and ADO-EGR2 with ocular Behcet’s disease in a Chinese Han population
por: Wu, Pengcheng, et al.
Publicado: (2018) -
Genetic susceptibility to psoriasis: an emerging picture
por: Smith, Rhodri Ll, et al.
Publicado: (2009) -
A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis
por: Yiu, Z.Z.N., et al.
Publicado: (2019) -
The Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) R620W Functional Polymorphism in Psoriasis
por: Bin Huraib, Ghaleb, et al.
Publicado: (2018)